Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an end. Catalysts in the drug production ...
Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...
One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 ...
Although Pfizer seems headed toward big things over the coming years, the stock has immediate appeal. Here are three reasons to consider buying Pfizer like there's no tomorrow -- today. 1.
A global pandemic propelled Pfizer’s stock to record highs after the company delivered the world’s first COVID-19 vaccine, but the pharmaceutical giant struggled to chart a new course as the ...
Price Action: PFE stock is down 1.47% at $29.75 at last check Thursday. Read Next: Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
In fact, investors traded out of the stock to the point that its price fell by 1.4%, comparing unfavorably to the 0.2% rise of the S&P 500 index on the day. Combination vaccine falls short in ...
Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...